Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 33 | 0 | 0 | 33 |
Chain A, HADH2 protein | 26 | 0 | 0 | 26 |
Chain B, HADH2 protein | 26 | 0 | 0 | 26 |
RAR-related orphan receptor gamma | 48 | 0 | 0 | 48 |
GLI family zinc finger 3 | 52 | 0 | 0 | 52 |
AR protein | 72 | 0 | 0 | 72 |
aldehyde dehydrogenase 1 family, member A1 | 42 | 0 | 0 | 42 |
thyroid stimulating hormone receptor | 23 | 0 | 0 | 23 |
estrogen receptor 2 (ER beta) | 31 | 0 | 0 | 31 |
nuclear receptor subfamily 1, group I, member 3 | 43 | 0 | 0 | 43 |
progesterone receptor | 43 | 0 | 0 | 43 |
glucocorticoid receptor [Homo sapiens] | 56 | 0 | 0 | 56 |
retinoic acid nuclear receptor alpha variant 1 | 53 | 0 | 0 | 53 |
estrogen-related nuclear receptor alpha | 54 | 0 | 0 | 54 |
pregnane X nuclear receptor | 58 | 0 | 0 | 58 |
estrogen nuclear receptor alpha | 76 | 0 | 0 | 76 |
aryl hydrocarbon receptor | 22 | 0 | 0 | 22 |
thyroid stimulating hormone receptor | 26 | 0 | 0 | 26 |
activating transcription factor 6 | 19 | 0 | 0 | 19 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 29 | 0 | 0 | 29 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 31 | 0 | 0 | 31 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 25 | 0 | 0 | 25 |
thyroid hormone receptor beta isoform 2 | 54 | 0 | 0 | 54 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 51 | 0 | 0 | 51 |
cytochrome P450 3A4 isoform 1 | 28 | 0 | 0 | 28 |
Gamma-aminobutyric acid receptor subunit pi | 28 | 11 | 1 | 40 |
Voltage-dependent calcium channel gamma-2 subunit | 26 | 0 | 0 | 26 |
Gamma-aminobutyric acid receptor subunit beta-1 | 28 | 11 | 1 | 40 |
Gamma-aminobutyric acid receptor subunit delta | 28 | 11 | 1 | 40 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 28 | 11 | 2 | 41 |
Glutamate receptor 2 | 26 | 4 | 1 | 32 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 28 | 11 | 1 | 40 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 28 | 11 | 1 | 40 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 28 | 11 | 1 | 40 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 28 | 11 | 1 | 40 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 28 | 11 | 1 | 40 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 28 | 11 | 1 | 40 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 28 | 11 | 1 | 40 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 28 | 11 | 2 | 41 |
Gamma-aminobutyric acid receptor subunit beta-3 | 28 | 11 | 1 | 40 |
Gamma-aminobutyric acid receptor subunit beta-2 | 28 | 11 | 2 | 41 |
Kelch-like ECH-associated protein 1 | 0 | 0 | 1 | 1 |
GABA theta subunit | 28 | 11 | 1 | 40 |
Gamma-aminobutyric acid receptor subunit epsilon | 28 | 11 | 1 | 40 |
Histone acetyltransferase KAT8 | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 22 | 0 | 0 | 22 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 14 | 0 | 0 | 14 |
Luciferase | 21 | 0 | 0 | 21 |
pregnane X receptor | 9 | 0 | 0 | 9 |
hypoxia-inducible factor 1 alpha subunit | 22 | 0 | 0 | 22 |
ATAD5 protein, partial | 27 | 0 | 0 | 27 |
thioredoxin glutathione reductase | 9 | 0 | 0 | 9 |
apical membrane antigen 1, AMA1 | 8 | 0 | 0 | 8 |
bromodomain adjacent to zinc finger domain 2B | 13 | 0 | 0 | 13 |
P53 | 2 | 0 | 0 | 2 |
peroxisome proliferator-activated receptor delta | 30 | 0 | 0 | 30 |
peroxisome proliferator activated receptor gamma | 41 | 0 | 0 | 41 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 35 | 0 | 0 | 35 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 34 | 0 | 0 | 34 |
chromobox protein homolog 1 | 34 | 0 | 0 | 34 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 21 | 0 | 0 | 21 |
potassium voltage-gated channel subfamily H member 2 isoform d | 27 | 0 | 0 | 27 |
histone deacetylase 9 isoform 3 | 5 | 0 | 0 | 5 |
importin subunit beta-1 isoform 1 | 12 | 0 | 0 | 12 |
mitogen-activated protein kinase 1 | 21 | 0 | 0 | 21 |
snurportin-1 | 12 | 0 | 0 | 12 |
GTP-binding nuclear protein Ran isoform 1 | 4 | 0 | 0 | 4 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 4 | 0 | 0 | 4 |
geminin | 62 | 0 | 0 | 62 |
histone acetyltransferase KAT2A isoform 1 | 19 | 0 | 0 | 19 |
lethal factor (plasmid) | 13 | 0 | 0 | 13 |
Cellular tumor antigen p53 | 50 | 0 | 0 | 50 |
Nuclear receptor ROR-gamma | 12 | 0 | 0 | 12 |
Rap guanine nucleotide exchange factor 4 | 3 | 0 | 0 | 3 |
Estrogen receptor | 1 | 17 | 6 | 25 |
Cytochrome P450 2C9 | 0 | 21 | 1 | 23 |
Estrogen receptor beta | 1 | 9 | 6 | 17 |
Chain A, Beta-lactamase | 16 | 0 | 0 | 16 |
Chain A, 2-oxoglutarate Oxygenase | 25 | 0 | 0 | 25 |
Skn7p | 0 | 0 | 0 | 1 |
Microtubule-associated protein tau | 24 | 0 | 0 | 24 |
nonstructural protein 1 | 8 | 0 | 0 | 8 |
euchromatic histone-lysine N-methyltransferase 2 | 62 | 0 | 0 | 62 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 8 | 0 | 0 | 8 |
survival motor neuron protein isoform d | 17 | 0 | 0 | 17 |
muscleblind-like protein 1 isoform 1 | 8 | 0 | 0 | 8 |
Rap guanine nucleotide exchange factor 3 | 6 | 0 | 0 | 6 |
TAR DNA-binding protein 43 | 12 | 0 | 0 | 12 |
HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
Kynureninase | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 28 | 4 | 33 |
5-hydroxytryptamine receptor 2A | 0 | 33 | 4 | 37 |
5-hydroxytryptamine receptor 1A | 0 | 33 | 4 | 40 |
Sodium-dependent noradrenaline transporter | 0 | 51 | 7 | 58 |
Sodium-dependent dopamine transporter | 0 | 19 | 3 | 22 |
5-hydroxytryptamine receptor 1B | 0 | 26 | 4 | 30 |
5-hydroxytryptamine receptor 1D | 0 | 14 | 4 | 18 |
5-hydroxytryptamine receptor 1F | 0 | 14 | 4 | 18 |
5-hydroxytryptamine receptor 2B | 0 | 25 | 4 | 29 |
5-hydroxytryptamine receptor 6 | 0 | 9 | 4 | 13 |
Sodium-dependent serotonin transporter | 0 | 57 | 9 | 66 |
Sodium-dependent serotonin transporter | 0 | 21 | 3 | 25 |
5-hydroxytryptamine receptor 7 | 0 | 14 | 4 | 18 |
5-hydroxytryptamine receptor 5A | 0 | 9 | 4 | 13 |
5-hydroxytryptamine receptor 5B | 0 | 9 | 4 | 13 |
5-hydroxytryptamine receptor 3A | 0 | 12 | 4 | 16 |
Sodium-dependent dopamine transporter | 0 | 36 | 6 | 42 |
5-hydroxytryptamine receptor 4 | 0 | 10 | 4 | 15 |
5-hydroxytryptamine receptor 3B | 0 | 12 | 4 | 16 |
Peptidylglycine alpha-amidating monooxygenase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 4 |
G-protein coupled bile acid receptor 1 | 0 | 0 | 2 | 2 |
thyroid hormone receptor beta isoform a | 18 | 0 | 0 | 18 |
Sex hormone-binding globulin | 0 | 0 | 12 | 12 |
Corticosteroid-binding globulin | 0 | 7 | 0 | 7 |
Mineralocorticoid receptor | 1 | 6 | 5 | 13 |
Androgen receptor | 0 | 21 | 0 | 21 |
Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 3 | 0 | 5 |
Guanine nucleotide-binding protein G | 6 | 0 | 0 | 6 |
Chain A, farnesyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
Geranylgeranyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
Farnesyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
Acetylcholinesterase | 0 | 11 | 0 | 11 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Farnesyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
Farnesyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 7 | 0 | 0 | 7 |
Chain A, Cruzipain | 15 | 0 | 0 | 15 |
thioredoxin reductase | 30 | 0 | 0 | 30 |
15-lipoxygenase, partial | 13 | 0 | 0 | 13 |
WRN | 2 | 0 | 0 | 2 |
phosphopantetheinyl transferase | 28 | 0 | 0 | 28 |
SMAD family member 2 | 18 | 0 | 0 | 18 |
USP1 protein, partial | 33 | 0 | 0 | 33 |
GLS protein | 32 | 0 | 0 | 32 |
SMAD family member 3 | 18 | 0 | 0 | 18 |
regulator of G-protein signaling 4 | 28 | 0 | 0 | 28 |
retinoid X nuclear receptor alpha | 40 | 0 | 0 | 40 |
farnesoid X nuclear receptor | 30 | 0 | 0 | 30 |
Caspase-7 | 4 | 0 | 0 | 4 |
Bloom syndrome protein isoform 1 | 14 | 0 | 0 | 14 |
phospholipase A2 precursor | 0 | 2 | 0 | 2 |
vitamin D3 receptor isoform VDRA | 24 | 0 | 0 | 24 |
caspase-3 | 4 | 0 | 0 | 4 |
heat shock protein beta-1 | 17 | 0 | 0 | 17 |
serine/threonine-protein kinase PLK1 | 3 | 0 | 0 | 3 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 13 | 0 | 0 | 13 |
DNA polymerase eta isoform 1 | 6 | 0 | 0 | 6 |
DNA polymerase iota isoform a (long) | 16 | 0 | 0 | 16 |
cysteine protease ATG4B isoform a | 0 | 2 | 0 | 2 |
DNA polymerase kappa isoform 1 | 21 | 0 | 0 | 21 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 3 | 1 | 0 | 4 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 2 | 0 | 0 | 2 |
lamin isoform A-delta10 | 48 | 0 | 0 | 48 |
Free fatty acid receptor 1 | 0 | 0 | 1 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 14 | 0 | 0 | 14 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 4 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
Trypsin | 0 | 3 | 0 | 3 |
Coagulation factor VII | 0 | 4 | 0 | 4 |
Aromatase | 0 | 9 | 0 | 9 |
Tissue factor | 0 | 6 | 0 | 6 |
Prostaglandin G/H synthase 1 | 0 | 5 | 0 | 5 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 6 | 6 |
Histamine H2 receptor | 24 | 7 | 0 | 39 |
Prostaglandin G/H synthase 2 | 0 | 5 | 0 | 6 |
Free fatty acid receptor 4 | 0 | 0 | 1 | 1 |
ATP-dependent phosphofructokinase | 25 | 0 | 0 | 25 |
TDP1 protein | 71 | 0 | 0 | 71 |
nuclear receptor ROR-gamma isoform 1 | 27 | 0 | 0 | 27 |
Bromodomain-containing protein 4 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 10 | 4 | 14 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 9 | 3 | 12 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 10 | 4 | 14 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 10 | 4 | 14 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 10 | 4 | 14 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 10 | 3 | 13 |
Cholecystokinin receptor type A | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 22 | 0 | 0 | 22 |
Ataxin-2 | 34 | 0 | 0 | 34 |
NFKB1 protein, partial | 8 | 0 | 0 | 8 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 44 | 0 | 0 | 44 |
cytochrome P450 2D6 | 38 | 0 | 0 | 38 |
arylsulfatase A | 23 | 0 | 0 | 23 |
cytochrome P450 2D6 isoform 1 | 23 | 0 | 0 | 23 |
D(1A) dopamine receptor | 23 | 0 | 0 | 23 |
atrial natriuretic peptide receptor 2 precursor | 10 | 0 | 0 | 10 |
serine/threonine-protein kinase mTOR isoform 1 | 14 | 0 | 0 | 14 |
muscarinic acetylcholine receptor M1 | 19 | 0 | 0 | 19 |
Solute carrier family 22 member 1 | 0 | 19 | 0 | 22 |
ATP-binding cassette sub-family C member 3 | 0 | 43 | 0 | 43 |
Multidrug resistance-associated protein 4 | 0 | 44 | 0 | 48 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 6 | 0 | 6 |
5-hydroxytryptamine receptor 4 | 0 | 32 | 0 | 32 |
Bile salt export pump | 0 | 64 | 0 | 64 |
Albumin | 0 | 0 | 8 | 8 |
High affinity nerve growth factor receptor | 0 | 1 | 2 | 3 |
Aldo-keto reductase family 1 member B1 | 0 | 34 | 0 | 34 |
Muscarinic acetylcholine receptor M2 | 0 | 25 | 0 | 25 |
Muscarinic acetylcholine receptor M4 | 0 | 26 | 0 | 26 |
Muscarinic acetylcholine receptor M1 | 0 | 9 | 0 | 9 |
Muscarinic acetylcholine receptor M3 | 0 | 7 | 0 | 7 |
Muscarinic acetylcholine receptor M4 | 0 | 7 | 0 | 7 |
Muscarinic acetylcholine receptor M5 | 0 | 9 | 0 | 9 |
Muscarinic acetylcholine receptor M5 | 0 | 29 | 0 | 29 |
Alpha-2A adrenergic receptor | 0 | 35 | 4 | 39 |
Muscarinic acetylcholine receptor M2 | 0 | 8 | 0 | 8 |
Muscarinic acetylcholine receptor M1 | 0 | 28 | 2 | 31 |
Angiotensin-converting enzyme | 0 | 19 | 0 | 19 |
D(2) dopamine receptor | 0 | 32 | 5 | 42 |
Alpha-2B adrenergic receptor | 0 | 34 | 1 | 35 |
Alpha-2C adrenergic receptor | 0 | 35 | 3 | 38 |
Muscarinic acetylcholine receptor M3 | 0 | 28 | 0 | 28 |
D(1A) dopamine receptor | 0 | 25 | 2 | 30 |
D(1B) dopamine receptor | 0 | 9 | 0 | 11 |
UDP-glucuronosyltransferase 1A4 | 0 | 2 | 0 | 6 |
Histamine H2 receptor | 0 | 20 | 0 | 20 |
Alpha-1D adrenergic receptor | 0 | 33 | 1 | 34 |
5-hydroxytryptamine receptor 2A | 0 | 41 | 2 | 44 |
5-hydroxytryptamine receptor 2C | 0 | 39 | 2 | 41 |
Histamine H1 receptor | 0 | 9 | 0 | 9 |
Histamine H1 receptor | 0 | 30 | 1 | 32 |
D(3) dopamine receptor | 0 | 33 | 3 | 39 |
Sodium channel protein type 1 subunit alpha | 0 | 4 | 0 | 4 |
Sodium channel protein type 4 subunit alpha | 0 | 6 | 0 | 8 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 4 |
5-hydroxytryptamine receptor 2B | 0 | 37 | 2 | 39 |
Alpha-1A adrenergic receptor | 0 | 32 | 2 | 34 |
D(1A) dopamine receptor | 12 | 2 | 0 | 14 |
5-hydroxytryptamine receptor 6 | 0 | 26 | 0 | 27 |
5-hydroxytryptamine receptor 7 | 0 | 10 | 0 | 10 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 5 | 0 | 5 |
Sodium channel protein type 7 subunit alpha | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 6 | 0 | 6 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 36 | 0 | 37 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 6 | 0 | 6 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 7 | 0 | 7 |
Sodium channel protein type 5 subunit alpha | 0 | 8 | 0 | 8 |
Sodium channel protein type 9 subunit alpha | 0 | 6 | 0 | 6 |
Sigma non-opioid intracellular receptor 1 | 0 | 9 | 2 | 11 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 17 | 0 | 17 |
Canalicular multispecific organic anion transporter 1 | 0 | 41 | 0 | 41 |
Sodium channel protein type 2 subunit alpha | 0 | 5 | 0 | 5 |
Sigma non-opioid intracellular receptor 1 | 0 | 30 | 0 | 30 |
Sodium channel protein type 3 subunit alpha | 0 | 5 | 0 | 5 |
Sodium channel protein type 11 subunit alpha | 0 | 3 | 0 | 3 |
Sodium channel protein type 8 subunit alpha | 0 | 3 | 0 | 3 |
Histamine H3 receptor | 0 | 7 | 0 | 7 |
Sodium channel protein type 10 subunit alpha | 0 | 4 | 0 | 4 |
glucocerebrosidase | 6 | 0 | 0 | 6 |
Atrial natriuretic peptide receptor 3 | 0 | 2 | 0 | 2 |
Type-1A angiotensin II receptor | 0 | 4 | 2 | 6 |
Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
Type-1B angiotensin II receptor | 0 | 4 | 0 | 4 |
Type-1 angiotensin II receptor | 0 | 4 | 3 | 9 |
Type-2 angiotensin II receptor | 0 | 7 | 0 | 7 |
Type-2 angiotensin II receptor | 0 | 3 | 0 | 3 |
Chain A, Ferritin light chain | 14 | 0 | 0 | 14 |
Corticotropin-releasing factor receptor 1 | 0 | 3 | 0 | 3 |
Corticotropin-releasing factor receptor 1 | 0 | 1 | 0 | 1 |
Corticotropin-releasing factor receptor 2 | 0 | 1 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 11 | 0 | 0 | 11 |
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain B, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain B, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Casein kinase II subunit alpha | 0 | 1 | 0 | 1 |
Chain A, Casein kinase II subunit alpha | 0 | 1 | 0 | 1 |
Chain A, Casein Kinase Ii Subunit Alpha | 0 | 1 | 0 | 1 |
interleukin 8 | 6 | 0 | 0 | 6 |
endonuclease IV | 5 | 0 | 0 | 5 |
BRCA1 | 2 | 0 | 0 | 2 |
RGS12 | 1 | 0 | 0 | 1 |
PPM1D protein | 8 | 0 | 0 | 8 |
Thrombopoietin | 7 | 0 | 0 | 7 |
Smad3 | 9 | 0 | 0 | 9 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 10 | 0 | 0 | 10 |
EWS/FLI fusion protein | 20 | 0 | 0 | 21 |
G | 29 | 0 | 0 | 29 |
Neuraminidase | 0 | 2 | 0 | 2 |
67.9K protein | 12 | 0 | 0 | 12 |
Parkin | 6 | 0 | 0 | 6 |
pyruvate kinase | 4 | 0 | 0 | 4 |
IDH1 | 14 | 0 | 0 | 14 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 13 | 0 | 0 | 13 |
Histone H2A.x | 16 | 0 | 0 | 16 |
Replicase polyprotein 1ab | 0 | 1 | 2 | 3 |
NPC intracellular cholesterol transporter 1 precursor | 7 | 0 | 0 | 7 |
peripheral myelin protein 22 isoform 1 | 11 | 0 | 0 | 11 |
hemoglobin subunit beta | 2 | 0 | 0 | 2 |
cellular tumor antigen p53 isoform a | 9 | 0 | 0 | 9 |
cytochrome P450 2C19 precursor | 13 | 0 | 0 | 13 |
cytochrome P450 2C9 precursor | 12 | 0 | 0 | 12 |
guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | 1 | 0 | 0 | 1 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 3 | 3 |
flap endonuclease 1 | 11 | 0 | 0 | 11 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 9 | 0 | 0 | 9 |
M-phase phosphoprotein 8 | 11 | 0 | 0 | 11 |
pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
neuropeptide S receptor isoform A | 11 | 0 | 0 | 11 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 7 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 7 | 1 | 8 |
Polyphenol oxidase 2 | 0 | 4 | 0 | 7 |
Aldo-keto reductase family 1 member B10 | 0 | 2 | 0 | 2 |
G2/mitotic-specific cyclin-B2 | 0 | 2 | 0 | 2 |
Poly [ADP-ribose] polymerase tankyrase-1 | 0 | 1 | 0 | 1 |
Lysozyme C-1 | 0 | 1 | 0 | 1 |
Cationic trypsin | 0 | 2 | 0 | 2 |
Carbonic anhydrase 1 | 0 | 7 | 0 | 13 |
Carbonic anhydrase 2 | 0 | 8 | 2 | 16 |
Interferon beta | 34 | 0 | 0 | 34 |
HLA class I histocompatibility antigen, B alpha chain | 29 | 0 | 0 | 29 |
Transthyretin | 0 | 2 | 4 | 8 |
Glucocorticoid receptor | 1 | 14 | 4 | 27 |
Cytochrome P450 1A1 | 0 | 5 | 0 | 5 |
Amyloid-beta precursor protein | 0 | 5 | 1 | 7 |
Integrin beta-3 | 6 | 0 | 1 | 7 |
Myeloperoxidase | 0 | 5 | 0 | 5 |
Cytochrome P450 1A2 | 0 | 7 | 0 | 9 |
Cyclin-dependent kinase 1 | 0 | 2 | 0 | 2 |
Beta-glucuronidase | 0 | 1 | 0 | 1 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 3 |
ATP-dependent translocase ABCB1 | 0 | 12 | 1 | 18 |
Neutrophil elastase | 0 | 2 | 0 | 2 |
Integrin alpha-IIb | 6 | 0 | 1 | 7 |
Ornithine decarboxylase | 1 | 0 | 0 | 1 |
Poly [ADP-ribose] polymerase 1 | 0 | 1 | 0 | 1 |
Replicase polyprotein 1a | 0 | 1 | 2 | 3 |
Replicase polyprotein 1ab | 0 | 1 | 2 | 3 |
Replicase polyprotein 1ab | 0 | 4 | 3 | 7 |
Replicase polyprotein 1ab | 0 | 4 | 3 | 7 |
Androgen receptor | 1 | 11 | 3 | 16 |
Sialidase | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase pim-1 | 0 | 2 | 0 | 3 |
Cystic fibrosis transmembrane conductance regulator | 0 | 1 | 1 | 2 |
17-beta-hydroxysteroid dehydrogenase type 1 | 0 | 3 | 0 | 4 |
Pyruvate kinase PKM | 0 | 1 | 0 | 1 |
G2/mitotic-specific cyclin-B1 | 0 | 2 | 0 | 2 |
Urease subunit alpha | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
G2/mitotic-specific cyclin-B | 0 | 1 | 0 | 1 |
Mucin-1 | 0 | 1 | 0 | 1 |
Glycogen synthase kinase-3 beta | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 9 | 2 | 11 |
Casein kinase II subunit alpha' | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 11 | 0 | 12 |
Carbonic anhydrase 4 | 0 | 5 | 0 | 9 |
Amine oxidase [flavin-containing] B | 0 | 11 | 0 | 12 |
Dipeptidyl peptidase 4 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-5 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 9 | 2 | 11 |
Substance-P receptor | 0 | 5 | 0 | 5 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 6 | 1 | 8 |
Mu-type opioid receptor | 0 | 15 | 6 | 24 |
Receptor-type tyrosine-protein kinase FLT3 | 0 | 1 | 0 | 1 |
Testosterone 17-beta-dehydrogenase 3 | 0 | 1 | 0 | 1 |
17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 2 | 0 | 2 |
Acetylcholinesterase | 0 | 1 | 0 | 3 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
Delta-type opioid receptor | 0 | 8 | 2 | 13 |
Kappa-type opioid receptor | 0 | 13 | 4 | 20 |
Homeobox protein Nkx-2.5 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase SYK | 0 | 1 | 1 | 2 |
Xanthine dehydrogenase/oxidase | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 9 | 2 | 11 |
Glycogen synthase kinase-3 alpha | 0 | 2 | 0 | 2 |
Glycogen synthase kinase-3 beta | 0 | 3 | 0 | 3 |
Estrogen receptor | 0 | 0 | 1 | 1 |
Death-associated protein kinase 1 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 10 | 0 | 1 | 0 | 1 |
Beta-secretase 1 | 0 | 2 | 0 | 3 |
Casein kinase II subunit beta | 0 | 1 | 0 | 1 |
Casein kinase II subunit alpha | 0 | 2 | 0 | 2 |
Urease subunit beta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 7 | 0 | 7 |
Disintegrin and metalloproteinase domain-containing protein 17 | 7 | 2 | 0 | 9 |
Lactoperoxidase | 0 | 2 | 0 | 2 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
MO15-related protein kinase Pfmrk | 0 | 1 | 0 | 1 |
Inositol monophosphatase 1 | 14 | 0 | 0 | 14 |
Cyclin-dependent kinase 6 | 0 | 1 | 0 | 1 |
Cyclin-dependent-like kinase 5 | 0 | 2 | 0 | 2 |
Cyclin homolog | 0 | 1 | 0 | 1 |
Transcription factor GATA-4 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 5 activator 1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 9 | 2 | 11 |
Mitogen-activated protein kinase 14 | 0 | 3 | 0 | 3 |
Cytochrome P450 1B1 | 0 | 8 | 0 | 8 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 5 | 2 | 16 |
Integrase | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 7 | 0 | 7 |
Casein kinase II subunit alpha 3 | 0 | 1 | 0 | 1 |
Inositol polyphosphate multikinase | 0 | 1 | 0 | 1 |
G2/mitotic-specific cyclin-B3 | 0 | 2 | 0 | 2 |
Inositol hexakisphosphate kinase 1 | 29 | 0 | 0 | 29 |
Enoyl-acyl-carrier protein reductase | 0 | 3 | 0 | 3 |
Aurora kinase B | 0 | 1 | 0 | 1 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 7 | 0 | 7 |
Myocilin | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
Prenyltransferase homolog | 0 | 0 | 0 | 2 |
Poly [ADP-ribose] polymerase tankyrase-2 | 0 | 2 | 0 | 2 |
MAP kinase-interacting serine/threonine-protein kinase 2 | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
NADPH oxidase 4 | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 3 | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 1 | 1 |
Inositol hexakisphosphate kinase 2 | 0 | 1 | 0 | 1 |
Short transient receptor potential channel 5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 7 | 0 | 7 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 8 | 0 | 9 |
Sialidase-2 | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 29 | 0 | 0 | 29 |
2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 3 | 0 | 0 | 3 |
acetylcholinesterase | 20 | 0 | 0 | 20 |
peripheral myelin protein 22 | 31 | 0 | 0 | 31 |
5-hydroxytryptamine receptor 1A | 0 | 15 | 9 | 24 |
Tryptophan 5-hydroxylase 1 | 0 | 5 | 0 | 5 |
Alpha-1B adrenergic receptor | 0 | 27 | 1 | 28 |
D | 0 | 19 | 0 | 21 |
D(3) dopamine receptor | 0 | 16 | 0 | 16 |
Alpha-2B adrenergic receptor | 0 | 18 | 1 | 19 |
D(2) dopamine receptor | 0 | 5 | 0 | 5 |
D(4) dopamine receptor | 0 | 14 | 2 | 19 |
Alpha-2C adrenergic receptor | 0 | 18 | 1 | 19 |
Alpha-2A adrenergic receptor | 0 | 18 | 1 | 19 |
Alpha-1D adrenergic receptor | 0 | 22 | 1 | 23 |
D(1B) dopamine receptor | 0 | 9 | 0 | 9 |
D(4) dopamine receptor | 0 | 11 | 1 | 12 |
Spike glycoprotein | 28 | 0 | 2 | 30 |
D(2) dopamine receptor | 0 | 27 | 4 | 32 |
E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
D | 0 | 2 | 0 | 2 |
D | 0 | 4 | 0 | 4 |
Chain A, ADIPOCYTE LIPID-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
caspase-1 isoform alpha precursor | 4 | 0 | 0 | 4 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 3 | 0 | 3 |
60 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
Fatty acid-binding protein, adipocyte | 0 | 1 | 1 | 2 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
10 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
Calmodulin | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 2 |
Fatty acid-binding protein 5 | 0 | 1 | 0 | 1 |
Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
Thiosulfate sulfurtransferase | 0 | 3 | 0 | 3 |
Lanosterol 14-alpha demethylase | 0 | 3 | 0 | 3 |
60 kDa chaperonin | 0 | 3 | 0 | 3 |
10 kDa chaperonin | 0 | 3 | 0 | 3 |
Solute carrier organic anion transporter family member 1B3 | 0 | 4 | 0 | 7 |
Cytosolic phospholipase A2 gamma | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 3 | 0 | 3 |
Solute carrier organic anion transporter family member 1B1 | 0 | 4 | 0 | 7 |
Translocator protein | 0 | 1 | 3 | 4 |
Vasopressin V2 receptor | 0 | 3 | 2 | 6 |
Oxytocin receptor | 0 | 3 | 3 | 6 |
Vasopressin V1a receptor | 0 | 1 | 2 | 3 |
Vasopressin V1a receptor | 0 | 3 | 2 | 5 |
Vasopressin V1b receptor | 0 | 2 | 2 | 4 |
Vasopressin V2 receptor | 0 | 0 | 1 | 1 |
Vasopressin V1b receptor | 0 | 2 | 1 | 4 |
Translocator protein | 0 | 1 | 0 | 2 |
Oxytocin receptor | 0 | 2 | 0 | 2 |
Vasopressin V2 receptor | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 3E | 0 | 5 | 1 | 6 |
Fumarate hydratase | 10 | 0 | 0 | 10 |
polyprotein | 10 | 0 | 0 | 10 |
lysosomal alpha-glucosidase preproprotein | 9 | 0 | 0 | 9 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
transcriptional regulator ERG isoform 3 | 9 | 0 | 0 | 9 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 2 | 0 | 6 | 0 | 7 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 3B | 0 | 5 | 1 | 6 |
Cytochrome P450 3A4 | 0 | 22 | 2 | 27 |
Neuronal acetylcholine receptor subunit alpha-4 | 3 | 2 | 1 | 6 |
Neuronal acetylcholine receptor subunit beta-2 | 3 | 2 | 1 | 6 |
Histamine H1 receptor | 0 | 3 | 1 | 6 |
5-hydroxytryptamine receptor 7 | 0 | 10 | 0 | 10 |
Alpha-1A adrenergic receptor | 0 | 12 | 1 | 13 |
Alpha-1B adrenergic receptor | 0 | 8 | 1 | 9 |
5-hydroxytryptamine receptor 3A | 0 | 6 | 1 | 7 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 3D | 0 | 5 | 1 | 6 |
Multidrug and toxin extrusion protein 2 | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 3C | 0 | 5 | 1 | 6 |
Multidrug and toxin extrusion protein 1 | 0 | 7 | 0 | 7 |
Metabotropic glutamate receptor 6 | 0 | 1 | 2 | 4 |
Excitatory amino acid transporter 4 | 0 | 2 | 0 | 2 |
Glutamate transporter homolog | 0 | 0 | 1 | 1 |
N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 2 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 12 | 1 | 17 |
Excitatory amino acid transporter 1 | 0 | 3 | 0 | 4 |
Excitatory amino acid transporter 2 | 0 | 3 | 0 | 4 |
Excitatory amino acid transporter 3 | 0 | 3 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 11 | 1 | 16 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 11 | 1 | 16 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 11 | 1 | 16 |
Metabotropic glutamate receptor 1 | 0 | 1 | 2 | 4 |
Metabotropic glutamate receptor 2 | 0 | 1 | 2 | 4 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 5 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 11 | 1 | 16 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 11 | 1 | 16 |
Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 11 | 1 | 16 |
Spike glycoprotein | 0 | 0 | 2 | 2 |
Transmembrane protease serine 2 | 0 | 0 | 2 | 2 |
Procathepsin L | 0 | 0 | 2 | 2 |
Angiotensin-converting enzyme 2 | 0 | 0 | 2 | 2 |
Chain A, D-MALTODEXTRIN BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, Limit Dextrinase | 0 | 0 | 1 | 1 |
Chain A, Solute-binding protein | 0 | 0 | 1 | 1 |
Chain A, Solute-binding protein | 0 | 0 | 1 | 1 |
Chain B, SusD | 0 | 0 | 1 | 1 |
Chain A, SusD | 0 | 0 | 1 | 1 |
Chain A, SusD | 0 | 0 | 1 | 1 |
Chain A, Alpha-hemolysin | 0 | 0 | 1 | 1 |
Chain B, Alpha-hemolysin | 0 | 0 | 1 | 1 |
Chain C, Alpha-hemolysin | 0 | 0 | 1 | 1 |
Chain D, Alpha-hemolysin | 0 | 0 | 1 | 1 |
Chain E, Alpha-hemolysin | 0 | 0 | 1 | 1 |
Chain F, Alpha-hemolysin | 0 | 0 | 1 | 1 |
Chain G, Alpha-hemolysin | 0 | 0 | 1 | 1 |
acid sphingomyelinase | 3 | 0 | 0 | 3 |
hypothetical protein, conserved | 4 | 0 | 0 | 4 |
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | 0 | 1 | 0 | 1 |
Chain A, Estrogen-related receptor gamma | 0 | 0 | 1 | 1 |
Chain A, Estrogen-related receptor gamma | 0 | 0 | 1 | 1 |
Chain A, Estrogen-related receptor gamma | 0 | 0 | 1 | 1 |
Chain A, Estrogen-related receptor gamma | 0 | 0 | 1 | 1 |
glp-1 receptor, partial | 13 | 0 | 0 | 13 |
GALC protein | 8 | 0 | 0 | 8 |
caspase 7, apoptosis-related cysteine protease | 11 | 0 | 0 | 11 |
caspase-3 | 11 | 0 | 0 | 11 |
GTPase KRas | 0 | 0 | 1 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 3 | 0 | 3 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 7 | 0 | 7 |
Estrogen-related receptor gamma | 0 | 1 | 0 | 1 |
GTP-binding protein Rheb | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid | 0 | 0 | 3 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 0 | 0 | 3 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 5 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 0 | 3 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 0 | 3 | 3 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 0 | 3 | 3 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 0 | 3 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 0 | 3 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 0 | 3 | 3 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 4 | 0 | 4 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 4 | 0 | 4 |
Sodium- and chloride-dependent betaine transporter | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 0 | 3 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 3 | 3 | 6 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 0 | 3 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 0 | 3 | 3 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 0 | 3 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 0 | 3 | 3 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 0 | 3 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 0 | 3 | 3 |
Genome polyprotein | 0 | 1 | 1 | 2 |
dopamine D1 receptor | 8 | 0 | 0 | 8 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
Beta-1 adrenergic receptor | 0 | 3 | 0 | 3 |
ATP-dependent translocase ABCB1 | 0 | 2 | 1 | 3 |
Alpha-synuclein | 4 | 5 | 1 | 10 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 3 | 2 | 5 |
Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 9 | 2 | 11 |
Acetylcholine receptor subunit alpha | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit gamma | 0 | 1 | 0 | 1 |
Integrin alpha-5 | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit beta | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 4 | 0 | 8 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1-6 | 0 | 2 | 0 | 3 |
Cytochrome P450 2B6 | 0 | 3 | 1 | 7 |
UDP-glucuronosyltransferase 1A1 | 0 | 4 | 0 | 5 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 1 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 9 | 0 | 10 |
UDP-glucuronosyltransferase 2B10 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 2 |
Acetylcholine receptor subunit delta | 0 | 1 | 0 | 1 |
Chain A, Glycogen Phosphorylase | 0 | 1 | 0 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Chitinase | 0 | 1 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 4 | 0 | 0 | 4 |
DNA polymerase beta | 10 | 0 | 0 | 10 |
Glycogen phosphorylase, muscle form | 0 | 2 | 0 | 2 |
Renin | 0 | 2 | 0 | 2 |
Cholinesterase | 0 | 6 | 0 | 6 |
Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 5 | 0 | 5 |
Adenosine receptor A1 | 0 | 5 | 1 | 9 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 4 | 0 | 4 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 6 | 1 | 8 |
Adenosine receptor A2b | 0 | 1 | 0 | 2 |
Adenosine receptor A2b | 0 | 2 | 1 | 4 |
Adenosine receptor A1 | 0 | 4 | 1 | 7 |
Adenosine receptor A2a | 0 | 4 | 2 | 10 |
Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Adenylate cyclase type 1 | 0 | 1 | 0 | 2 |
Chitotriosidase-1 | 0 | 1 | 0 | 1 |
Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 1 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 2 | 2 | 4 |
Endochitinase B1 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 1 | 0 | 2 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
Guanine deaminase | 0 | 1 | 0 | 1 |
Chain A, Vitamin D Nuclear Receptor | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 0 | 1 | 1 |
Vitamin D-binding protein | 0 | 0 | 1 | 1 |
Cytochrome P450 2D6 | 0 | 16 | 0 | 16 |
Vitamin D3 receptor | 0 | 1 | 2 | 4 |
Vitamin D3 receptor | 0 | 1 | 1 | 3 |
Retinoic acid receptor RXR-alpha | 0 | 1 | 3 | 4 |
Vitamin D3 receptor | 0 | 0 | 1 | 1 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 1 | 1 | 2 |
Transporter | 0 | 6 | 0 | 6 |
Vitamin D3 receptor A | 0 | 0 | 2 | 2 |
Vpr | 4 | 0 | 0 | 4 |
Bile salt export pump | 0 | 7 | 0 | 7 |
Major prion protein | 0 | 0 | 3 | 3 |
Sodium channel protein type 1 subunit alpha | 0 | 5 | 0 | 5 |
Sodium channel protein type 2 subunit alpha | 0 | 3 | 0 | 3 |
Sodium channel protein type 3 subunit alpha | 0 | 3 | 0 | 3 |
Cytochrome P450 2J2 | 0 | 11 | 0 | 11 |
Frizzled-8 | 0 | 0 | 1 | 1 |
P2X purinoceptor 4 | 0 | 2 | 0 | 2 |
Chain A, serum paraoxonase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 3 | 0 | 7 |
Carbonic anhydrase 3 | 0 | 3 | 0 | 7 |
Neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 6 | 0 | 4 | 0 | 8 |
Carbonic anhydrase 5A, mitochondrial | 0 | 4 | 0 | 8 |
Carbonic anhydrase 7 | 0 | 3 | 0 | 7 |
Carbonic anhydrase 9 | 0 | 5 | 1 | 10 |
Carbonic anhydrase 13 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 14 | 0 | 3 | 0 | 7 |
Carbonic anhydrase 5B, mitochondrial | 0 | 3 | 0 | 7 |
thyrotropin-releasing hormone receptor | 4 | 0 | 0 | 4 |
Caspase-2 | 0 | 0 | 1 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 2 |
DNA gyrase subunit A | 0 | 2 | 0 | 4 |
DNA gyrase subunit B | 0 | 2 | 0 | 4 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 2 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 2 |
DNA topoisomerase 2-alpha | 0 | 1 | 0 | 4 |
DNA gyrase subunit A | 0 | 1 | 0 | 2 |
Multidrug resistance protein MdtK | 0 | 0 | 1 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 2 | 0 | 3 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 1 |
Sodium-dependent noradrenaline transporter | 0 | 4 | 0 | 4 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Aromatase | 0 | 1 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 7 | 0 | 7 |
Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
Sodium-dependent dopamine transporter | 0 | 6 | 0 | 6 |
Sigma non-opioid intracellular receptor 1 | 0 | 9 | 2 | 11 |
Transporter | 0 | 20 | 0 | 20 |
Trypanothione reductase | 0 | 2 | 0 | 2 |
Trypanothione reductase | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-6 | 0 | 0 | 1 | 1 |
Envelope glycoprotein | 0 | 0 | 4 | 4 |
Beta-1 adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-1B adrenergic receptor | 0 | 0 | 3 | 3 |
Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 5 | 0 | 5 |
Alpha-1A adrenergic receptor | 0 | 0 | 3 | 3 |
Alpha-2B adrenergic receptor | 0 | 1 | 0 | 2 |
Delta-type opioid receptor | 0 | 6 | 2 | 10 |
Mu-type opioid receptor | 0 | 8 | 2 | 10 |
Alpha-2C adrenergic receptor | 0 | 1 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Nischarin | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 8 | 0 | 8 |
Nischarin | 0 | 3 | 0 | 3 |
Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
Chain H, Fab M82G2, Heavy chain | 0 | 0 | 1 | 1 |
Chain L, Fab M82G2, Light chain | 0 | 0 | 1 | 1 |
Chain H, Fab M82g2, Heavy Chain | 0 | 0 | 1 | 1 |
Chain L, Fab M82g2, Light Chain | 0 | 0 | 1 | 1 |
Fatty acid-binding protein, heart | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
Liver carboxylesterase 1 | 0 | 1 | 0 | 4 |
Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 3 | 0 | 4 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 3 | 0 | 3 |
Leukotriene B4 receptor 1 | 0 | 1 | 0 | 1 |
Leukotriene B4 receptor 2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 3 | 0 | 3 |
C-8 sterol isomerase | 0 | 2 | 0 | 2 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 2 | 0 | 7 | 0 | 7 |
Glycine receptor subunit alpha-1 | 0 | 14 | 0 | 14 |
Glycine receptor subunit beta | 0 | 14 | 0 | 14 |
Glycine receptor subunit alpha-2 | 0 | 14 | 0 | 14 |
Glycine receptor subunit alpha-3 | 0 | 14 | 0 | 14 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 4 | 4 |
Cytochrome P450 2A6 | 0 | 4 | 0 | 4 |
Cytochrome P450 2A5 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
Proton-coupled amino acid transporter 1 | 0 | 2 | 0 | 2 |
Chain A, Breast cancer type 1 susceptibility protein | 2 | 0 | 0 | 2 |
Nrf2 | 1 | 0 | 0 | 1 |
alkaline phosphatase, intestinal | 0 | 1 | 0 | 1 |
PINK1 | 3 | 0 | 0 | 3 |
toll-like receptor 9 | 0 | 1 | 0 | 1 |
TPA: protein transporter TIM10 | 0 | 1 | 0 | 1 |
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 1 | 0 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 3 | 0 | 0 | 3 |
perilipin-5 | 0 | 1 | 0 | 1 |
intestinal alkaline phosphatase precursor | 0 | 1 | 0 | 1 |
perilipin-1 | 0 | 1 | 0 | 1 |
huntingtin isoform 2 | 9 | 0 | 0 | 9 |
pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 2 | 0 | 1 | 3 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 9 | 0 | 0 | 9 |
tumor susceptibility gene 101 protein | 2 | 0 | 0 | 2 |
urokinase-type plasminogen activator precursor | 10 | 0 | 0 | 10 |
plasminogen precursor | 10 | 0 | 0 | 10 |
urokinase plasminogen activator surface receptor precursor | 10 | 0 | 0 | 10 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
alkaline phosphatase, germ cell type preproprotein | 0 | 1 | 0 | 1 |
hypothetical protein SA1422 | 0 | 1 | 0 | 1 |
Prostaglandin E synthase | 0 | 1 | 0 | 1 |
Histone deacetylase 3 | 0 | 5 | 0 | 5 |
Acetylcholinesterase | 0 | 5 | 0 | 5 |
Lysine-specific histone demethylase 1A | 0 | 4 | 0 | 5 |
D-amino-acid oxidase | 0 | 1 | 0 | 1 |
Phospholipase A2 | 0 | 1 | 0 | 1 |
Neuronal proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 7 | 1 | 8 |
Heme oxygenase 1 | 0 | 1 | 0 | 1 |
Glutathione S-transferase P | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 3 | 0 | 3 |
Microtubule-associated protein tau | 0 | 1 | 0 | 2 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 1 | 0 | 1 |
Tyrosinase | 0 | 3 | 0 | 3 |
Aminopeptidase N | 0 | 1 | 0 | 1 |
Aminopeptidase N | 0 | 1 | 0 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Heme oxygenase 2 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Caspase-7 | 3 | 0 | 0 | 3 |
Histone deacetylase 4 | 0 | 5 | 0 | 5 |
Cholinesterase | 0 | 4 | 0 | 4 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
Histone acetyltransferase p300 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase PAK 1 | 0 | 2 | 0 | 2 |
Histone deacetylase 1 | 0 | 6 | 0 | 6 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 1 | 2 |
Sodium/bile acid cotransporter | 0 | 0 | 1 | 1 |
Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 2 | 4 |
Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 1 |
Thioredoxin reductase 3 | 0 | 1 | 0 | 1 |
Sortase A | 0 | 1 | 0 | 1 |
Histone deacetylase 7 | 0 | 5 | 0 | 5 |
Histone deacetylase 2 | 0 | 6 | 0 | 6 |
CREB-binding protein | 0 | 1 | 0 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | 0 | 2 | 0 | 2 |
Cysteine protease | 0 | 1 | 0 | 1 |
Polyamine deacetylase HDAC10 | 0 | 5 | 0 | 5 |
Histone deacetylase 11 | 0 | 5 | 0 | 5 |
Histone deacetylase 8 | 0 | 6 | 0 | 6 |
Thioredoxin reductase 2, mitochondrial | 0 | 1 | 0 | 1 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Histone deacetylase 6 | 0 | 5 | 0 | 5 |
Histone deacetylase 9 | 0 | 5 | 0 | 5 |
Histone deacetylase 5 | 0 | 5 | 0 | 5 |
Lymphocyte antigen 96 | 0 | 0 | 1 | 1 |
Beta lactamase (plasmid) | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 2 | 0 | 5 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 4 |
Steryl-sulfatase | 0 | 1 | 0 | 2 |
Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 3 |
Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 5 |
ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 2 |
Solute carrier family 22 member 11 | 0 | 0 | 0 | 3 |
Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 2 |
Albumin | 0 | 1 | 3 | 4 |
Histamine H3 receptor | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 4 | 0 | 1 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 2 | 9 | 0 | 0 | 9 |
Phenylethanolamine N-methyltransferase | 0 | 2 | 0 | 2 |
Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 2 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 2 | 2 |
Trace amine-associated receptor 1 | 0 | 0 | 2 | 2 |
Trace amine-associated receptor 1 | 0 | 0 | 3 | 3 |
Cereblon isoform 4 | 0 | 2 | 0 | 2 |
Insulin-like growth factor-binding protein 5 | 0 | 0 | 1 | 1 |
Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
Protein cereblon | 0 | 2 | 0 | 2 |
prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 1 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 1 | 3 |
Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 1 | 3 |
Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 1 | 3 |
Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 1 | 3 |
Prostacyclin receptor | 0 | 2 | 1 | 3 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 20 | 0 | 4 | 0 | 4 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 3 |
Solute carrier family 22 member 6 | 0 | 4 | 0 | 4 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Histamine N-methyltransferase | 0 | 0 | 0 | 1 |
Calcium release-activated calcium channel protein 1 | 0 | 1 | 0 | 1 |
Protein orai-2 | 0 | 1 | 0 | 1 |
Protein orai-3 | 0 | 1 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 0 | 0 | 2 |
Chain A, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
Chain A, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
Chain B, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
Chain A, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
Chain B, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
Chain A, Pol Polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol Polyprotein | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 2 | 0 | 2 |
Gag-Pol polyprotein | 0 | 4 | 0 | 4 |
Gag-Pol polyprotein | 0 | 2 | 0 | 2 |
Cannabinoid receptor 1 | 0 | 3 | 0 | 3 |
Microsomal triglyceride transfer protein large subunit | 0 | 2 | 0 | 2 |
Envelope glycoprotein gp160 [Cleaved into: Surface protein gp120 | 0 | 1 | 0 | 1 |
Protease | 0 | 3 | 0 | 4 |
Fructose-1,6-bisphosphatase 1 | 0 | 0 | 0 | 2 |
Reverse transcriptase | 0 | 2 | 2 | 4 |
Cholesterol 24-hydroxylase | 0 | 0 | 1 | 1 |
Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta)) | 0 | 1 | 0 | 1 |
Oxoeicosanoid receptor 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 5 | 0 | 5 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 5 | 0 | 5 |
serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
streptokinase A precursor | 0 | 0 | 1 | 1 |
Estrogen receptor | 0 | 0 | 2 | 2 |
Tyrosine-protein kinase Fyn | 0 | 5 | 0 | 5 |
Estrogen receptor beta | 0 | 0 | 2 | 2 |
hexokinase-4 isoform 1 | 3 | 0 | 0 | 3 |
glucokinase regulatory protein | 3 | 0 | 0 | 3 |
Mu-type opioid receptor | 0 | 11 | 4 | 18 |
Ghrelin O-acyltransferase | 0 | 1 | 0 | 1 |
Cytochrome P450 2B1 | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 3 | 0 | 3 |
Sulfotransferase 1A1 | 0 | 2 | 1 | 4 |
Aldehyde oxidase | 0 | 3 | 0 | 3 |
Nuclear receptor subfamily 1 group I member 3 | 0 | 1 | 0 | 1 |
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 2 | 0 | 2 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 2 | 0 | 2 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 2 | 0 | 2 |
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase | 0 | 1 | 0 | 1 |
ras-related protein Rab-9A | 8 | 0 | 0 | 8 |
Cytochrome P450 2C8 | 0 | 4 | 0 | 4 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily C member 1 | 0 | 2 | 0 | 2 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 3 | 0 | 3 |
Cytochrome P450 1A2 | 0 | 2 | 0 | 2 |
Chain A, Dihydrofolate reductase | 0 | 0 | 1 | 1 |
alpha-galactosidase | 4 | 0 | 0 | 4 |
Thymidylate synthase | 0 | 4 | 0 | 4 |
Thymidylate synthase | 0 | 3 | 0 | 3 |
Dihydrofolate reductase | 0 | 4 | 3 | 7 |
Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 4 |
Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 4 |
Multidrug resistance associated protein | 0 | 1 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit rho-3 | 0 | 0 | 1 | 1 |
Hsf1 protein | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit rho-1 | 0 | 0 | 2 | 2 |
Gamma-aminobutyric acid receptor subunit rho-2 | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent taurine transporter | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 0 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 0 | 0 | 1 |
Sterol O-acyltransferase 1 | 0 | 0 | 1 | 1 |
Platelet glycoprotein VI | 0 | 1 | 2 | 4 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 1 | 0 | 1 |
Asialoglycoprotein receptor 1 | 0 | 1 | 1 | 2 |
Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | 0 | 1 | 0 | 1 |
Chain A, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
Chain B, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
Chain A, Slr1257 protein | 0 | 0 | 1 | 1 |
Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] | 0 | 1 | 0 | 1 |
beta-2 adrenergic receptor | 2 | 0 | 0 | 2 |
Metabotropic glutamate receptor 8 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 3 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 3 | 0 | 3 |
Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
Bifunctional aspartokinase/homoserine dehydrogenase 1 | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 0 | 2 | 2 |
ATP-citrate synthase | 0 | 1 | 0 | 1 |
Glutamate receptor 1 | 0 | 4 | 1 | 6 |
Glutamate receptor 3 | 0 | 4 | 1 | 6 |
Glutamate receptor 4 | 0 | 4 | 1 | 6 |
Glutamate receptor ionotropic, kainate 1 | 0 | 3 | 1 | 5 |
Metabotropic glutamate receptor 1 | 0 | 3 | 1 | 4 |
Metabotropic glutamate receptor 2 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 3 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 4 | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 6 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 7 | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, kainate 1 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 3 |
Glutamate receptor ionotropic, kainate 2 | 0 | 3 | 1 | 5 |
Glutamate receptor 1 | 0 | 2 | 1 | 3 |
Glutamate receptor 2 | 0 | 2 | 1 | 3 |
Glutamate receptor 3 | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, kainate 3 | 0 | 3 | 0 | 4 |
Metabotropic glutamate receptor 8 | 0 | 0 | 1 | 1 |
Glutamate receptor 4 | 0 | 2 | 1 | 3 |
Excitatory amino acid transporter 3 | 0 | 0 | 0 | 1 |
Glutamate racemase | 0 | 0 | 0 | 1 |
Metabotropic glutamate receptor 8 | 0 | 2 | 1 | 3 |
Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, kainate 4 | 0 | 3 | 0 | 4 |
Glutamate carboxypeptidase 2 | 0 | 1 | 0 | 2 |
Glutamate receptor ionotropic, kainate 2 | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, kainate 3 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 4 | 0 | 4 |
Metabotropic glutamate receptor 7 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 3 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 3 | 0 | 3 |
Glutamate receptor ionotropic, kainate 5 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 5 | 0 | 3 | 0 | 4 |
Glutamate racemase | 0 | 0 | 0 | 1 |
Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 3 | 0 | 3 |
Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
Adenylate cyclase type 1 | 0 | 1 | 0 | 1 |
transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
Cocaine esterase | 0 | 2 | 0 | 2 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 3 |
Vitamin D-binding protein | 0 | 1 | 0 | 1 |
HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
Integrin beta-1 | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
Integrin alpha-4 | 0 | 1 | 0 | 1 |
Carbonyl reductase [NADPH] 1 | 0 | 2 | 0 | 3 |
Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
Adenylate cyclase type 3 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 4 | 0 | 4 |
Beta-3 adrenergic receptor | 0 | 1 | 0 | 1 |
Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 4 | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 8 | 3 | 12 |
5-hydroxytryptamine receptor 2C | 0 | 3 | 0 | 3 |
Kappa-type opioid receptor | 0 | 6 | 3 | 10 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
Adenylate cyclase type 8 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
AP-2 complex subunit sigma | 0 | 1 | 0 | 1 |
N-acetyltransferase Eis | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Adenylate cyclase type 6 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
Calcitonin gene-related peptide type 1 receptor | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 2 | 0 | 2 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Zinc finger protein 664 | 0 | 1 | 0 | 1 |
Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
Adenylyl cyclase 7 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 0 | 1 |
Chain A, Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 1 | 0 | 1 |
Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
CDC-like kinase 1, isoform CRA_c | 0 | 0 | 0 | 1 |
[Tau protein] kinase | 0 | 1 | 0 | 1 |
dual specificity protein kinase CLK4 | 1 | 0 | 0 | 1 |
Dual specificity protein kinase CLK2 | 0 | 1 | 0 | 1 |
Dual specificity protein kinase CLK3 | 0 | 1 | 0 | 1 |
Dual specificity protein kinase CLK4 | 0 | 1 | 0 | 1 |
Dual specificity tyrosine-phosphorylation-regulated kinase 3 | 0 | 1 | 0 | 1 |
Cyclin-T1 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase D3 | 0 | 1 | 0 | 1 |
Protein kinase C gamma type | 0 | 1 | 0 | 1 |
Protein kinase C beta type | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Lck | 0 | 3 | 1 | 4 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Lyn | 0 | 1 | 0 | 1 |
Protein kinase C alpha type | 0 | 1 | 1 | 2 |
Cyclin-A2 | 0 | 1 | 0 | 1 |
Dual specificity protein kinase CLK1 | 0 | 1 | 0 | 1 |
Protein kinase C eta type | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 2 | 0 | 1 | 1 | 2 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
Neuromedin-B receptor | 0 | 1 | 0 | 1 |
Protein kinase C iota type | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
Casein kinase I isoform delta | 0 | 1 | 0 | 1 |
Casein kinase I isoform epsilon | 0 | 1 | 0 | 1 |
Dual specificity protein kinase CLK1 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 7 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 9 | 0 | 1 | 0 | 1 |
Cyclin-H | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
Cyclin-A1 | 0 | 1 | 0 | 1 |
Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
Protein kinase C theta type | 0 | 1 | 0 | 1 |
Protein kinase C zeta type | 0 | 1 | 0 | 1 |
Protein kinase C delta type | 0 | 1 | 0 | 1 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 2 | 0 | 2 |
Serine/threonine-protein kinase D1 | 0 | 1 | 0 | 1 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase pim-3 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase haspin | 0 | 1 | 0 | 1 |
Dual specificity tyrosine-phosphorylation-regulated kinase 2 | 0 | 1 | 0 | 1 |
Dual specificity tyrosine-phosphorylation-regulated kinase 4 | 0 | 1 | 0 | 1 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1B | 0 | 2 | 0 | 2 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 1 | 0 | 1 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 2 | 0 | 2 |
luciferase | 1 | 0 | 0 | 1 |
Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 1 |
Dopamine beta-hydroxylase | 0 | 1 | 0 | 1 |
Cystathionine beta-synthase | 0 | 1 | 0 | 1 |
Glutathione reductase | 0 | 1 | 0 | 1 |
5-lipoxygenase | 0 | 1 | 0 | 1 |
Cysteine protease ATG4B | 0 | 1 | 0 | 1 |
Thioredoxin reductase 2, mitochondrial | 0 | 1 | 0 | 1 |
Acid-sensing ion channel 3 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 5 | 0 | 6 |
Epidermal growth factor receptor | 0 | 3 | 0 | 3 |
Fatty acid-binding protein, liver | 0 | 3 | 0 | 3 |
Albumin | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, intestinal | 0 | 2 | 0 | 2 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Caspase-1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
Aldo-keto reductase family 1 member C3 | 0 | 3 | 0 | 3 |
Caspase-3 | 0 | 1 | 0 | 1 |
Caspase-4 | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Caspase-5 | 0 | 1 | 0 | 1 |
Caspase-9 | 0 | 1 | 0 | 1 |
Acid-sensing ion channel 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 2 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
Snq2p | 0 | 0 | 0 | 1 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
D(2) dopamine receptor | 0 | 3 | 0 | 3 |
7,8-dihydro-8-oxoguanine triphosphatase | 0 | 1 | 0 | 1 |
Toll-like receptor 8 | 0 | 0 | 1 | 1 |
Toll-like receptor 7 | 0 | 0 | 1 | 1 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 13 | 0 | 1 | 0 | 1 |
Aryl hydrocarbon receptor | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase 12 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 11 | 0 | 1 | 0 | 1 |
G protein-coupled receptor GPR35 | 0 | 0 | 1 | 1 |
Vesicular glutamate transporter 3 | 0 | 1 | 0 | 1 |
G-protein coupled receptor 35 | 0 | 2 | 1 | 3 |
Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
Gonadotropin-releasing hormone receptor | 0 | 1 | 0 | 1 |
Gonadotropin-releasing hormone receptor | 0 | 2 | 0 | 2 |
integrase, partial | 0 | 1 | 0 | 1 |
lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
Plasma kallikrein | 0 | 0 | 0 | 3 |
Carbonic anhydrase | 0 | 0 | 0 | 3 |
Solute carrier family 15 member 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 4 |
Large neutral amino acids transporter small subunit 1 | 0 | 3 | 0 | 3 |
SLC16A10 protein | 0 | 0 | 0 | 3 |
Carbonic anhydrase | 0 | 0 | 0 | 3 |
Carbonic anhydrase | 0 | 0 | 0 | 3 |
Carbonic anhydrase | 0 | 1 | 0 | 4 |
Carbonic anhydrase | 0 | 0 | 0 | 3 |
Monocarboxylate transporter 10 | 0 | 0 | 0 | 3 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 4 |
Carbonic anhydrase 13 | 0 | 0 | 0 | 3 |
phosphoglycerate kinase | 2 | 0 | 0 | 2 |
Progesterone receptor | 0 | 8 | 5 | 16 |
Translocator protein | 0 | 1 | 0 | 1 |
Neprilysin | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Thromboxane A2 receptor | 0 | 1 | 0 | 2 |
Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
Squalene synthase | 0 | 2 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
Androgen receptor | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
ClpP | 3 | 0 | 0 | 3 |
Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 4 | 1 | 5 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Nociceptin receptor | 0 | 1 | 1 | 2 |
Melatonin receptor type 1A | 0 | 4 | 2 | 6 |
Melatonin receptor type 1C | 0 | 0 | 1 | 1 |
Melatonin receptor type 1A | 0 | 2 | 2 | 4 |
Melatonin receptor type 1B | 0 | 4 | 2 | 6 |
Melatonin receptor type 1C | 0 | 2 | 2 | 4 |
Melatonin receptor type 1B | 0 | 2 | 2 | 4 |
Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 4 | 2 | 8 |
Mu-type opioid receptor | 0 | 4 | 2 | 9 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Dopamine beta-hydroxylase | 0 | 2 | 0 | 2 |
Lactoperoxidase | 0 | 1 | 0 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 1 | 0 | 1 |
transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
nuclear receptor coactivator 3 isoform a | 0 | 1 | 0 | 1 |
Toll-like receptor 4 | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase ABL1 | 0 | 1 | 1 | 3 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Folate receptor beta | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Folate receptor alpha | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Histidine decarboxylase | 0 | 1 | 2 | 3 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
Bifunctional purine biosynthesis protein ATIC | 0 | 2 | 0 | 2 |
Reduced folate transporter | 0 | 2 | 0 | 2 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Pteridine reductase 1 | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
Serine racemase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 3 | 0 | 3 |
Endothelin receptor type B | 1 | 1 | 0 | 2 |
Endothelin receptor type B | 0 | 1 | 0 | 1 |
Endothelin-1 receptor | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
G-protein coupled receptor | 0 | 1 | 0 | 1 |
Chain A, PROGESTERONE RECEPTOR | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 1 | 0 | 1 |
Tegument protein VP16 | 0 | 0 | 1 | 1 |
Glucocorticoid receptor | 0 | 2 | 2 | 5 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Thyroid hormone receptor alpha | 0 | 3 | 3 | 6 |
Thyroid hormone receptor beta | 0 | 3 | 3 | 6 |
Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
Progesterone receptor | 0 | 0 | 1 | 1 |
Glucocorticoid receptor | 0 | 1 | 0 | 1 |
Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
Opioid receptor homologue | 0 | 1 | 0 | 1 |
Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
Neuropeptide Y receptor type 1 | 0 | 2 | 0 | 2 |
Neuropeptide Y receptor type 2 | 0 | 2 | 0 | 2 |
Chain B, Hiv-1 Reverse Transcriptase | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Reverse Transcriptase | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Reverse Transcriptase | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Reverse Transcriptase | 0 | 1 | 0 | 1 |
Chain B, Hiv-1 Reverse Transcriptase | 0 | 1 | 0 | 1 |
Chain A, Reverse transcriptase/ribonuclease H | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Imidazoleglycerol-phosphate dehydratase | 0 | 1 | 0 | 1 |
Ryanodine receptor 1 | 0 | 1 | 0 | 1 |
Exoribonuclease H | 0 | 1 | 0 | 1 |
Cardiac ryanodine receptor 2 | 0 | 1 | 0 | 1 |
Nociceptin receptor | 0 | 1 | 3 | 4 |
Nociceptin receptor | 0 | 2 | 2 | 5 |
Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
FAD-linked sulfhydryl oxidase ALR | 0 | 0 | 0 | 2 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Quinolone resistance protein NorA | 0 | 1 | 0 | 1 |
Beta-adrenergic receptor kinase 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
Beta-adrenergic receptor kinase 1 | 0 | 1 | 1 | 2 |
Substance-P receptor | 0 | 3 | 1 | 4 |
Rhodopsin kinase GRK1 | 0 | 1 | 0 | 1 |
G protein-coupled receptor kinase 5 | 0 | 1 | 0 | 1 |
G protein-coupled receptor kinase 5 | 0 | 1 | 0 | 1 |
P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
Rhodopsin kinase GRK1 | 0 | 1 | 0 | 1 |
Beta-adrenergic receptor kinase 1 | 0 | 0 | 0 | 1 |
Chain A, TRYPSIN | 0 | 1 | 0 | 1 |
Chain A, TRYPSIN | 0 | 1 | 0 | 1 |
Chain A, TRYPSIN | 0 | 1 | 0 | 1 |
Chain A, TRYPSIN | 0 | 1 | 0 | 1 |
Chain A, TRYPSIN | 0 | 1 | 0 | 1 |
Chain A, TRYPSIN | 0 | 1 | 0 | 1 |
Flavodoxin | 0 | 0 | 0 | 1 |
Membrane primary amine oxidase | 0 | 0 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 0 | 0 | 1 |
Membrane primary amine oxidase | 0 | 0 | 0 | 1 |
Lysyl oxidase homolog 2 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor DM1 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
Taste receptor type 2 member 31 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 60 | 0 | 0 | 1 | 1 |
Sodium/potassium/calcium exchanger 4 | 0 | 1 | 1 | 2 |
Taste receptor type 2 member 14 | 0 | 0 | 1 | 2 |
Taste receptor type 2 member 13 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 9 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 4 | 0 | 0 | 1 | 1 |
Sodium/potassium/calcium exchanger 2 | 0 | 1 | 1 | 2 |
luciferase | 0 | 0 | 0 | 1 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Pyridoxal kinase | 0 | 0 | 0 | 1 |
Lysine-specific demethylase 4E | 0 | 1 | 0 | 1 |
runt-related transcription factor 1 isoform AML1b | 1 | 0 | 0 | 1 |
core-binding factor subunit beta isoform 2 | 1 | 0 | 0 | 1 |
Advanced glycosylation end product-specific receptor | 0 | 0 | 1 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Advanced glycosylation end product-specific receptor | 0 | 0 | 1 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-2 | 0 | 1 | 0 | 1 |
Chain A, Troponin C, slow skeletal and cardiac muscles | 0 | 0 | 1 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
M18 aspartyl aminopeptidase | 0 | 1 | 0 | 1 |
cathepsin L1 | 0 | 1 | 0 | 1 |
Vif | 0 | 1 | 0 | 1 |
transcription factor p65 isoform 1 | 0 | 0 | 1 | 1 |
serine/threonine-protein kinase 33 isoform a | 0 | 0 | 1 | 1 |
POsterior Segregation | 0 | 0 | 1 | 1 |
Aryl hydrocarbon receptor | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 1 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 1 | 1 | 2 |
Myc proto-oncogene protein | 0 | 1 | 0 | 2 |
Cathepsin D | 0 | 1 | 0 | 1 |
Luciferin 4-monooxygenase | 0 | 1 | 0 | 1 |
DNA polymerase alpha catalytic subunit | 0 | 1 | 0 | 1 |
Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Breakpoint cluster region protein | 0 | 1 | 0 | 2 |
Tyrosinase | 0 | 2 | 0 | 2 |
Ornithine decarboxylase | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 0 | 1 | 1 |
Nuclear factor NF-kappa-B p105 subunit | 0 | 1 | 0 | 1 |
Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
Endothelin-1 receptor | 1 | 0 | 0 | 1 |
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 | 0 | 1 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
Alpha-glucosidase MAL12 | 0 | 1 | 0 | 1 |
Nuclear factor NF-kappa-B p100 subunit | 0 | 1 | 0 | 1 |
Transcription factor p65 | 0 | 1 | 0 | 1 |
Bcl-2-like protein 1 | 0 | 1 | 0 | 1 |
N1L | 0 | 1 | 0 | 1 |
NAD(P)H dehydrogenase [quinone] 1 | 0 | 0 | 0 | 2 |
Tubulin beta-2B chain | 0 | 1 | 0 | 1 |
Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 1 | 0 | 1 |
Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-2 | 0 | 0 | 1 | 1 |
NAD-dependent protein deacetylase sirtuin-1 | 0 | 0 | 1 | 3 |
NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 0 | 0 | 1 | 1 |
Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
large T antigen | 0 | 1 | 0 | 1 |
Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR | 0 | 0 | 1 | 1 |
Retinol-binding protein 4 | 0 | 0 | 1 | 1 |
Beta-lactoglobulin | 0 | 0 | 1 | 1 |
Chain A, 6,7-Dimethyl-8-ribityllumazine Synthase | 0 | 0 | 1 | 1 |
Chain B, 6,7-Dimethyl-8-ribityllumazine Synthase | 0 | 0 | 1 | 1 |
Chain H, Immunoglobulin Igg1 Heavy chain | 0 | 0 | 1 | 1 |
Chain L, Immunoglobulin Igg1 Lambda Light Chain | 0 | 0 | 1 | 1 |
Chain A, DODECIN | 0 | 0 | 1 | 1 |
Chain A, DODECIN | 0 | 0 | 1 | 1 |
Chain C, DODECIN | 0 | 0 | 1 | 1 |
Chain E, DODECIN | 0 | 0 | 1 | 1 |
NPYLR7B | 0 | 0 | 1 | 1 |
tumor necrosis factor | 1 | 0 | 0 | 1 |
Riboflavin-binding protein | 0 | 1 | 1 | 2 |
Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
RmtA | 0 | 1 | 0 | 1 |
Protein arginine N-methyltransferase 1 | 0 | 1 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 0 | 1 | 1 |
Adenylate cyclase type 6 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 3 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 9 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
D(1) dopamine receptor | 0 | 1 | 0 | 1 |
Adenylate cyclase type 8 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 7 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 4 | 0 | 1 | 0 | 1 |
Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 2 | 0 | 2 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Substance-K receptor | 0 | 1 | 1 | 2 |
Substance-K receptor | 0 | 2 | 0 | 2 |
Neuromedin-K receptor | 0 | 1 | 1 | 2 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Growth hormone secretagogue receptor type 1 | 0 | 0 | 1 | 1 |
Chain A, MALTOPORIN | 0 | 0 | 1 | 1 |
Chain B, MALTOPORIN | 0 | 0 | 1 | 1 |
Chain A, ykoF | 0 | 0 | 1 | 1 |
Chain B, ykoF | 0 | 0 | 1 | 1 |
Chain A, ThiT | 0 | 0 | 1 | 1 |
Thiamine transporter ThiT | 0 | 0 | 1 | 1 |
Transketolase | 0 | 0 | 1 | 1 |
Thiamine-binding periplasmic protein | 0 | 0 | 1 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
Proliferating cell nuclear antigen | 0 | 2 | 0 | 2 |
Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 2 |
Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
Bile acid receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Cytochrome P450 2E1 | 0 | 1 | 0 | 1 |
Cytochrome P450 4B1 | 0 | 1 | 0 | 1 |
Cytochrome P450 3A5 | 0 | 1 | 0 | 1 |
Cytochrome P450 2A7 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Cytochrome P450 3A7 | 0 | 1 | 0 | 1 |
Cytochrome P450 2F1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C18 | 0 | 1 | 0 | 1 |
Cytochrome P450 4F2 | 0 | 1 | 0 | 1 |
Cytochrome P450 4F8 | 0 | 1 | 0 | 1 |
Cytochrome P450 4A11 | 0 | 1 | 0 | 1 |
Cytochrome P450 4F3 | 0 | 1 | 0 | 1 |
Cytochrome P450 2A13 | 0 | 1 | 0 | 1 |
Cytochrome P450 4A22 | 0 | 1 | 0 | 1 |
Vitamin D 25-hydroxylase | 0 | 1 | 0 | 1 |
Cytochrome P450 2U1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2W1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2S1 | 0 | 1 | 0 | 1 |
Cytochrome P450 3A43 | 0 | 1 | 0 | 1 |
REST corepressor 3 | 0 | 1 | 0 | 1 |
Chain A, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain C, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain A, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain C, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain A, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain C, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain A, Repressor | 0 | 0 | 1 | 1 |
3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
twin arginine protein translocation system - TatA protein | 0 | 0 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
Endoplasmic reticulum chaperone BiP | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | 0 | 2 | 0 | 2 |
Enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Enoyl-ACP reductase II | 0 | 1 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 1 |
Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 4A1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 1 | 0 | 1 |
Chain A, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
Chain K, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
Chain B, tryptophanyl-tRNA synthetase | 0 | 0 | 1 | 1 |
Chain C, Tryptophanyl-tRNA synthetase II | 0 | 0 | 1 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
Stromelysin-1 | 0 | 1 | 0 | 1 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 2 |
Tryptophan 2,3-dioxygenase | 0 | 1 | 0 | 2 |
Tryprostatin B synthase | 0 | 0 | 0 | 1 |
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | 0 | 0 | 1 | 1 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
Chain A, CHORISMATE MUTASE | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-tRNA SYNTHETASE | 0 | 0 | 1 | 1 |
Tubulin--tyrosine ligase | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B7 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
Aspartate aminotransferase, cytoplasmic | 0 | 1 | 0 | 1 |
Sphingosine-1-phosphate lyase 1 | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |